Clinical Trial Update: A Study of R1507 in Participants With Recurrent or Refractory Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of R1507 in recurrent or refractory sarcoma was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• R1507

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2021-02-03